Literature DB >> 8479702

Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells.

B M Glaser1, J Vidaurri-Leal, R G Michels, P A Campochiaro.   

Abstract

BACKGROUND: Retinal pigment epithelial (RPE) cells are a major component of contractile cellular membranes in proliferative vitreoretinopathy (PVR). Displacement of viable RPE cells into the vitreous cavity is necessary for membrane formation. This study examines the effect of cryotherapy during surgery for giant retinal tears on the dispersion of viable cells into the vitreous cavity.
METHODS: A total of seven eyes undergoing vitrectomy and retinal reattachment surgery were studied. Vitreous fluid from three eyes was aspirated immediately after cryotherapy; fluid from four eyes was aspirated after scleral indentation with the cryoprobe, but without cryotherapy. Colonies of pigmented cells routinely grew in flasks inoculated with fluid from eyes treated with cryotherapy. In contrast, flasks inoculated with fluid from eyes not treated with cryotherapy contained significantly fewer viable cells.
CONCLUSION: Cryotherapy performed during retinal reattachment surgery in eyes with giant retinal tears is likely to enhance intravitreal dispersion of viable RPE cells. The findings in this study suggest that possible harmful effects of cryotherapy should be evaluated further and that alternative methods of creating a chorioretinal adhesion should be considered in cases with an especially high risk of PVR.

Entities:  

Mesh:

Year:  1993        PMID: 8479702     DOI: 10.1016/s0161-6420(93)31620-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

Review 1.  [Scleral buckling surgery and pneumatic retinopexy. Techniques, indications and results].

Authors:  H Hoerauf; H Heimann; L Hansen; H Laqua
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

2.  Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR.

Authors:  M Bonnet; S Guenoun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

Review 3.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

4.  Conjunctival pigmentation after 23-gauge microincisional vitrectomy surgery.

Authors:  D H Park; J P Shin; S Y Kim
Journal:  Eye (Lond)       Date:  2011-08-19       Impact factor: 3.775

5.  Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

Authors:  M Bonnet; J Fleury; S Guenoun; A Yaniali; C Dumas; C Hajjar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

6.  Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

Authors:  N Duquesne; M Bonnet; P Adeleine
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

7.  Diode laser contact transscleral retinal photocoagulation: a clinical study.

Authors:  D A McHugh; S Schwartz; J G Dowler; M Ulbig; R K Blach; P A Hamilton
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

8.  Bilateral rhegmatogenous retinal detachment after external-beam radiotherapy: just a coincidence?

Authors:  Laurent Kodjikian; Justus G Garweg; Jacques Fleury; François Rocher; Carole Burillon; Jean-Daniel Grange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-24       Impact factor: 3.117

9.  Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease.

Authors:  H Mietz; K Heimann
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

10.  Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats' disease.

Authors:  Ayman G Elnahry; Essam M Sallam; Kirollos J Guirguis; Joseph H Talbet; Ahmed A Abdel-Kader
Journal:  Am J Ophthalmol Case Rep       Date:  2019-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.